Article
ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer.
Oncotarget - 20 Feb 2015
Choe Min Ho, Min Joong Won, Jeon Hong Bae, Cho Dong-Hyung, Oh Jeong Su, Lee Hyun Gyu, Hwang Sang-Gu, An Sungkwan, Han Young-Hoon, Kim Jae-Sung
Abstract excerpt
Although targeting radioresistant tumor cells is essential for enhancing the efficacy of radiotherapy, the signals activated in resistant tumors are still unclear. This study shows that ERp57 contributes to radioresistance of laryngeal cancer by activating STAT3. Increased ERp57 was associated with the radioresistant phenotype of laryngeal cancer cells. Interestingly, increased interaction between ERp57 and STAT3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
